Progress in identifying peptides and small-molecule inhibitors targeted to gp41 of HIV-1

Expert Opinion on Investigational Drugs
A K Debnath

Abstract

During the last decade, a great number of activities have been geared in identifying newer targets for inhibiting HIV infection as well as understanding the targets for already identified anti-HIV-1 agents. The success in converting a proof-of-concept peptide T-20 (previously named DP-178), from the C-terminal heptad repeat (CHR) region of the envelope glycoprotein gp41 of HIV-1, to a drug named enfuvirtide was one of the phenomenal successes in HIV-1 drug discovery research that has been made in recent years. There were many reports of modifying peptides from the N-terminal heptad repeat and CHR regions with the objective of improving their activity. A few laboratories also reported the identification of small-molecule inhibitors that apparently bind to the hydrophobic cavity identified in the gp41 core structure and prevent the CHR peptide binding to the N-terminal heptad repeat peptide, thereby prevent the formation of the typical six-helix bundle, which has been thought to be necessary for the fusion between HIV and cell membranes.

References

Nov 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C WildT Matthews
Nov 1, 1993·AIDS Research and Human Retroviruses·C WildT Matthews
Sep 9, 1993·Nature·S JiangA R Neurath
Sep 15, 1993·Biochemical and Biophysical Research Communications·S JiangA R Neurath
Jan 1, 1995·SAR and QSAR in Environmental Research·C Hansch, L Zhang
Dec 1, 1995·Nature Structural Biology·M LuP S Kim
Nov 14, 1997·Proceedings of the National Academy of Sciences of the United States of America·K TanM Lu
Feb 12, 1998·Proceedings of the National Academy of Sciences of the United States of America·J K JudiceR S McDowell
Jan 24, 1998·Journal of Biomolecular Structure & Dynamics·M Lu, P S Kim
Dec 5, 1998·Journal of Molecular Biology·D M EckertP S Kim
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·D C ChanP S Kim
Mar 18, 2000·Biochemical and Biophysical Research Communications·S Jiang, A K Debnath
Dec 5, 2000·Journal of Acquired Immune Deficiency Syndromes : JAIDS·C L TremblayM S Hirsch
Mar 7, 2001·Science·M J RootP S Kim
Mar 29, 2001·Journal of Pharmacological and Toxicological Methods·C A Lipinski
Jun 8, 2001·Annual Review of Biochemistry·D M Eckert, P S Kim
Sep 27, 2001·Proceedings of the National Academy of Sciences of the United States of America·D M Eckert, P S Kim
Feb 23, 2002·The Journal of Biological Chemistry·Carole A BewleyG Marius Clore
Apr 12, 2002·Current Pharmaceutical Design·Shibo JiangAsim K Debnath
Jun 27, 2002·Biochimica Et Biophysica Acta·Erik De Clercq
Oct 25, 2002·AIDS Research and Human Retroviruses·Qian ZhaoShibo Jiang
Nov 6, 2002·Proceedings of the National Academy of Sciences of the United States of America·Samuel K SiaPeter S Kim
May 21, 2003·Nature Reviews. Drug Discovery·Jason LaBontePeter Kirkpatrick
Jul 23, 2003·Current Medicinal Chemistry·José A Esté
Dec 12, 2003·The New England Journal of Medicine·Robert C Gallo, Luc Montagnier
Jun 8, 2004·Current Pharmaceutical Design·Michael J Root, H Kirby Steger
Dec 8, 2004·Current Drug Targets. Infectious Disorders·Stefano RusconiClaudiu T Supuran

❮ Previous
Next ❯

Citations

Nov 24, 2007·Current Opinion in Biotechnology·Ming-Qiang Zhang, Barrie Wilkinson
Feb 28, 2008·The Journal of Biological Chemistry·Yuxian HeLinqi Zhang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Lancet
José A Esté, Amalio Telenti
Acta Pharmacologica Sinica
Elias KrambovitisDemetrios A Spandidos
Current Pharmaceutical Design
M J Root, H Kirby Steger
© 2022 Meta ULC. All rights reserved